Home › Companies › CARTESIAN THERAPEUTICS INC. › 2024-2025
At CARTESIAN THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held September 20, 2024 and June 13, 2025), 94 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 745 separate fund positions. On the most widely held item of the season, voted at the meeting held June 13, 2025 — To approve, on a non-binding and advisory basis, a resolution approving the compensation of… — CARTESIAN THERAPEUTICS INC.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CARTESIAN THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 16, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CARTESIAN THERAPEUTICS INC.’s Form 8-K, filed June 16, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 13, 2025: 5 items on CARTESIAN THERAPEUTICS INC.’s Form 8-K, filed June 16, 2025: 3 elected · 2 approved.
Meeting of September 20, 2024: 2 items on CARTESIAN THERAPEUTICS INC.’s Form 8-K, filed September 23, 2024: 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CARTESIAN THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CARTESIAN THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 16, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. CARTESIAN THERAPEUTICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Timothy C. Barabe, M.B.A. | 19,208,637 | -- | -- | 651,344 | 2,008,823 | 97% | Elected | — |
| Elect Director: Carsten Brunn, Ph.D. | 19,841,557 | -- | -- | 18,424 | 2,008,823 | 99.9% | Elected | — |
| Elect Director: Nishan de Silva, M.D., M.B.A. | 19,840,306 | -- | -- | 19,675 | 2,008,823 | 99.9% | Elected | — |
| 2. Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company's named executive officers | 19,701,123 | 157,132 | 1,726 | -- | 2,008,823 | 99.2% | Approved | — |
| 3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 21,830,780 | 5,946 | 32,078 | -- | -- | 99.9% | Approved | — |
Source: CARTESIAN THERAPEUTICS INC., Form 8-K, filed with the SEC on June 16, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Approval of the issuance of shares of the Company's Common Stock upon conversion of the Company's Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") | 12,514,261 | 150,060 | 1,650 | -- | -- | 99% | Approved | — |
| 2. Approval of the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal 1 | 16,076,183 | 151,789 | 1,246 | -- | -- | 99.0% | Approved | — |
Source: CARTESIAN THERAPEUTICS INC., Form 8-K, filed with the SEC on September 23, 2024 — read the filing on EDGAR.
Each item below shows how the 94 asset managers that disclosed a CARTESIAN THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held June 13, 2025.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Carsten Brunn, Ph.D.
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“Elect Director: Carsten Brunn, Ph.D.”): 19,841,557 for, 18,424 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,518,420 | 0 | 0 | 0 | For |
| BlackRock | 51,929 | 0 | 0 | 0 | For |
| Vanguard | 24,203 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,769 | 0 | 0 | 0 | For |
| JPMorgan | 15,308 | 0 | 0 | 0 | For |
| Equitable | 8,467 | 0 | 0 | 0 | For |
| Northern Trust | 8,319 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,933 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,262 | 0 | 0 | 0 | For |
| Brighthouse | 4,828 | 0 | 0 | 0 | For |
| Pacific Life | 2,629 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 1,940 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,899 | 0 | 0 | 0 | For |
| Global X | 1,618 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,343 | 0 | 0 | 0 | For |
| TIAA | 980 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| ProShares | 465 | 0 | 0 | 0 | For |
| State Street | 404 | 0 | 0 | 0 | For |
| Nationwide | 256 | 0 | 0 | 0 | For |
| Voya | 218 | 0 | 0 | 0 | For |
| John Hancock | 175 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 160 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 1,681,700 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 260,011 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 260,011 for.
Meeting held June 13, 2025.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Nishan de Silva, MD MBA
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“Elect Director: Nishan de Silva, M.D., M.B.A.”): 19,840,306 for, 19,675 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,518,420 | 0 | 0 | 0 | For |
| BlackRock | 51,929 | 0 | 0 | 0 | For |
| Vanguard | 24,203 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,769 | 0 | 0 | 0 | For |
| JPMorgan | 15,308 | 0 | 0 | 0 | For |
| Equitable | 8,467 | 0 | 0 | 0 | For |
| Northern Trust | 8,319 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,933 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,262 | 0 | 0 | 0 | For |
| Brighthouse | 4,828 | 0 | 0 | 0 | For |
| Pacific Life | 2,629 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 1,940 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,899 | 0 | 0 | 0 | For |
| Global X | 1,618 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,343 | 0 | 0 | 0 | For |
| TIAA | 980 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| ProShares | 465 | 0 | 0 | 0 | For |
| State Street | 404 | 0 | 0 | 0 | For |
| Nationwide | 256 | 0 | 0 | 0 | For |
| Voya | 218 | 0 | 0 | 0 | For |
| John Hancock | 175 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 160 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 1,681,661 for, 39 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 260,011 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 260,011 for.
Meeting held June 13, 2025.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Timothy C. Barabe, MBA
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“Elect Director: Timothy C. Barabe, M.B.A.”): 19,208,637 for, 651,344 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,518,420 | 0 | 0 | 0 | For |
| BlackRock | 51,929 | 0 | 0 | 0 | For |
| Vanguard | 24,203 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,643 | 0 | 0 | 7,126 | Mixed |
| JPMorgan | 15,308 | 0 | 0 | 0 | For |
| Equitable | 2,392 | 0 | 0 | 6,075 | Mixed |
| Northern Trust | 0 | 0 | 0 | 8,319 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 5,933 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 5,262 | Withhold |
| Brighthouse | 0 | 0 | 0 | 4,828 | Withhold |
| Pacific Life | 2,629 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 0 | 1,940 | Withhold |
| Bridge Builder Trust | 1,899 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 1,618 | Withhold |
| DWS | 0 | 0 | 0 | 1,600 | Withhold |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 1,343 | Withhold |
| TIAA | 0 | 0 | 0 | 980 | Withhold |
| Calvert | 0 | 0 | 0 | 708 | Withhold |
| ProShares | 0 | 0 | 0 | 465 | Withhold |
| State Street | 0 | 0 | 0 | 404 | Withhold |
| Nationwide | 256 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 218 | Withhold |
| John Hancock | 0 | 0 | 175 | 0 | Abstain |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 160 | Withhold |
Fund voting reports, all 33 managers: 1,640,312 for, 41,213 withheld, 175 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 260,011 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 260,011 for.
Meeting held September 20, 2024.
Combines 4 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock, par value $0.0001 per share ("Common Stock"), of Cartesian Therapeutics, Inc. (the "Company") upon conversion of the Company's Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Conversion Proposal" or "Proposal No. 1"); and
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“1. Approval of the issuance of shares of the Company's Common Stock upon conversion of the Company's Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock")”): 12,514,261 for, 150,060 against — passed, per its Form 8-K filed September 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In order to comply with applicable Nasdaq rules, the Company instructed the inspector of elections to conduct a separate tabulation that subtracted 3,563,247 shares of Common Stock from the total number of shares of Common Stock that voted in favor of Proposal 1 to determine whether Proposal 1 was …”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,794,985 | 0 | 0 | 0 | For |
| Vanguard | 81,893 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,475 | 5,726 | 0 | 0 | Mixed |
| JPMorgan | 27,041 | 0 | 0 | 0 | For |
| BlackRock | 16,255 | 0 | 0 | 0 | For |
| Brighthouse | 8,830 | 0 | 0 | 0 | For |
| Northern Trust | 7,559 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 3,000 | 0 | 0 | 0 | For |
| Equitable | 2,516 | 0 | 0 | 0 | For |
| Pacific Life | 2,513 | 0 | 0 | 0 | For |
| TIAA | 2,144 | 0 | 0 | 0 | For |
| John Hancock | 1,537 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,376 | 0 | 0 | 0 | For |
| Nationwide | 1,150 | 0 | 0 | 0 | For |
| Global X | 1,090 | 0 | 0 | 0 | For |
| Charles Schwab | 1,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 871 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| State Street | 0 | 578 | 0 | 0 | Against |
| Voya | 297 | 0 | 0 | 0 | For |
| ProShares | 264 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 215 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 160 | 0 | 0 | Against |
| DWS | 150 | 0 | 0 | 0 | For |
| Morgan Stanley | 65 | 0 | 0 | 0 | For |
Fund voting reports, all 29 managers: 1,978,049 for, 6,490 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 260,011 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 260,011 for.
Meeting held September 20, 2024.
Combines 2 wordings of this item as funds reported it.
99.0% Approved · of votes cast
Description as filed by funds: To approve the adjournment or postponement of the special meeting of stockholders of the Company (the "Special Meeting"), if necessary, to continue to solicit votes for Proposal No. 1 (the "Adjournment Proposal" or "Proposal No. 2").
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“2. Approval of the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal 1”): 16,076,183 for, 151,789 against — passed, per its Form 8-K filed September 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders of the Company approved Proposal 2.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 1,978,043 for, 6,496 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,794,985 | 0 | 0 | 0 | For |
| Vanguard | 81,893 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,475 | 5,726 | 0 | 0 | Mixed |
| JPMorgan | 27,041 | 0 | 0 | 0 | For |
| BlackRock | 16,255 | 0 | 0 | 0 | For |
| Brighthouse | 8,830 | 0 | 0 | 0 | For |
| Northern Trust | 7,559 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 3,000 | 0 | 0 | 0 | For |
| Equitable | 2,516 | 0 | 0 | 0 | For |
| Pacific Life | 2,513 | 0 | 0 | 0 | For |
| TIAA | 2,144 | 0 | 0 | 0 | For |
| John Hancock | 1,537 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,376 | 0 | 0 | 0 | For |
| Nationwide | 1,150 | 0 | 0 | 0 | For |
| Global X | 1,090 | 0 | 0 | 0 | For |
| Charles Schwab | 1,048 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 871 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| State Street | 0 | 578 | 0 | 0 | Against |
| Voya | 297 | 0 | 0 | 0 | For |
| ProShares | 264 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 215 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 160 | 0 | 0 | Against |
| DWS | 150 | 0 | 0 | 0 | For |
| Morgan Stanley | 65 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Meeting held June 13, 2025.
Combines 7 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation.
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“2. Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company's named executive officers”): 19,701,123 for, 157,132 against — passed, per its Form 8-K filed June 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of our named executive officers.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,518,420 | 0 | 0 | 0 | For |
| BlackRock | 51,929 | 0 | 0 | 0 | For |
| Vanguard | 24,203 | 0 | 0 | 0 | For |
| Lincoln Financial | 7,126 | 15,643 | 0 | 0 | Mixed |
| JPMorgan | 0 | 15,308 | 0 | 0 | Against |
| Equitable | 2,392 | 6,075 | 0 | 0 | Mixed |
| Northern Trust | 8,319 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,933 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,262 | 0 | 0 | 0 | For |
| Brighthouse | 4,828 | 0 | 0 | 0 | For |
| Pacific Life | 2,629 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 1,940 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,899 | 0 | 0 | 0 | For |
| Global X | 1,618 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,343 | 0 | 0 | 0 | For |
| TIAA | 980 | 0 | 0 | 0 | For |
| Calvert | 0 | 708 | 0 | 0 | Against |
| ProShares | 465 | 0 | 0 | 0 | For |
| State Street | 404 | 0 | 0 | 0 | For |
| Nationwide | 256 | 0 | 0 | 0 | For |
| Voya | 218 | 0 | 0 | 0 | For |
| John Hancock | 175 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 160 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 1,643,743 for, 37,856 against, 101 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,977,045 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 272,110 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 142,233 | 0 | 0 | 0 | For |
| Citadel | 121,572 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 113,746 | 0 | 0 | Against |
| State Street | 95,687 | 11 | 0 | 0 | For |
| BlackRock | 73,826 | 2,667 | 0 | 0 | For |
| MPM BioImpact LLC | 72,568 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 48,072 | 0 | 0 | 0 | For |
| Northern Trust | 41,200 | 0 | 0 | 0 | For |
| Freestone Capital Holdings, LLC | 25,921 | 0 | 0 | 0 | For |
| DELPHI FINANCIAL GROUP, INC. | 22,028 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 13,946 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 9,114 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 6,075 | 0 | 0 | Against |
| Vanguard | 5,976 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,001 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 3,902 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 3,333 | 0 | 0 | 0 | For |
| Invesco | 0 | 2,154 | 0 | 0 | Against |
| RBC Dominion Securities Inc. | 2,133 | 0 | 0 | 0 | For |
| MetLife Investment Management, LLC | 2,117 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 2,048 | 0 | 0 | 0 | For |
| Rhumbline | 1,919 | 2 | 0 | 0 | For |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
Institutional-manager reports, all 74 managers: 2,951,249 for, 128,426 against, 103 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 13, 2025.
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as Cartesian Therapeutics, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2025.
CARTESIAN THERAPEUTICS INC.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 21,830,780 for, 5,946 against — passed, per its Form 8-K filed June 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,518,420 | 0 | 0 | 0 | For |
| BlackRock | 51,929 | 0 | 0 | 0 | For |
| Vanguard | 24,203 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,769 | 0 | 0 | 0 | For |
| JPMorgan | 15,308 | 0 | 0 | 0 | For |
| Equitable | 8,467 | 0 | 0 | 0 | For |
| Northern Trust | 8,319 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,933 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,262 | 0 | 0 | 0 | For |
| Brighthouse | 4,828 | 0 | 0 | 0 | For |
| Pacific Life | 2,629 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 1,940 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,899 | 0 | 0 | 0 | For |
| Global X | 1,618 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| Charles Schwab | 1,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,343 | 0 | 0 | 0 | For |
| TIAA | 980 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| ProShares | 465 | 0 | 0 | 0 | For |
| State Street | 404 | 0 | 0 | 0 | For |
| Nationwide | 256 | 0 | 0 | 0 | For |
| Voya | 218 | 0 | 0 | 0 | For |
| John Hancock | 175 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 160 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 1,681,700 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 260,011 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 260,011 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 25,954,291 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 5.85% |
| 2 | BlackRock | 0.20% |
| 3 | Vanguard | 0.09% |
| 4 | Lincoln Financial | 0.09% |
| 5 | JPMorgan | 0.06% |
| 6 | Equitable | 0.03% |
| 7 | Northern Trust | 0.03% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.02% |
| 9 | AIG/SunAmerica | 0.02% |
| 10 | Brighthouse | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 7.62% |
| 2 | Siren, L.L.C. | 1.05% |
| 3 | Erste Asset Management GmbH | 0.55% |
| 4 | Citadel | 0.47% |
| 5 | JPMorgan | 0.44% |
| 6 | State Street | 0.37% |
| 7 | BlackRock | 0.29% |
| 8 | MPM BioImpact LLC | 0.28% |
| 9 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.19% |
| 10 | Northern Trust | 0.16% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with Timothy A. Springer, Ph.D. | — | DEF14A |
| Timothy A. Springer | — | 13D |
| Murat Kalayoglu | — | 13D |
| Entities affiliated with Murat Kalayoglu, M.D., Ph.D. | — | DEF14A |
| FMR (Fidelity) | — | 13F |
| Squarepoint Ops LLC | — | 13G |
| FMR LLC | — | 13G |
| Michael S. Singer, M.D., Ph.D. | — | DEF14A |
| BlackRock | — | 13F |
| Vanguard Group | — | 13F |
Percentages above are of 25,954,291 shares outstanding, as reported by CARTESIAN THERAPEUTICS INC. on its Form 10-Q dated April 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CARTESIAN THERAPEUTICS INC.’s 10-Q dated April 30, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
CARTESIAN THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “CARTESIAN THERAPEUTICS (RNAC) 2024-2025 Annual & Special Meetings”, https://proxyvotesnow.com/company/cartesian-therapeutics-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.